(VIANEWS) – PennyMac (PFSI), Capital Product Partners L.P. (CPLP), Towers Watson & Co (TW) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. PennyMac (PFSI)
44% sales growth and 4.13% return on equity
PennyMac Financial Services, Inc., through its subsidiaries, engages in the mortgage banking and investment management activities in the United States. The company operates through three segments: Production, Servicing, and Investment Management. The Production segment is involved in the origination, acquisition, and sale of loans. This segment sources residential conventional and government-insured or guaranteed mortgage loans through correspondent production, consumer direct lending, and broker direct lending. The Servicing segment performs loan servicing for both newly originated loans that are under holding for sale and loans services for others. The segment performs loan administration, collection, and default management activities, including the collection and remittance of loan payments; responds to customer inquiries; provides accounting for principal and interest; holds custodial funds for the payment of property taxes and insurance premiums; counsels delinquent borrowers; and supervising foreclosures and property dispositions, as well as administers loss mitigation activities, such as modification and forbearance programs. The Investment Management segment is involved in sourcing, performing diligence, bidding, and closing investment asset acquisitions; managing correspondent production activities for PennyMac Mortgage Investment Trust; and managing acquired assets. The company was founded in 2008 and is headquartered in Westlake Village, California.
Earnings Per Share
As for profitability, PennyMac has a trailing twelve months EPS of $2.74.
PE Ratio
PennyMac has a trailing twelve months price to earnings ratio of 32.52. Meaning, the purchaser of the share is investing $32.52 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.13%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
PennyMac’s EBITDA is 8.3.
2. Capital Product Partners L.P. (CPLP)
31.8% sales growth and 5.21% return on equity
Capital Product Partners L.P., a shipping company, provides marine transportation services in Greece. Its vessels transports a range of dry cargoes and containerized goods under short-term voyage charters, and medium to long-term time and bareboat charters. As of April 26, 2021, the company owned 17 vessels, including thirteen Neo-Panamax container vessels, three Panamax container vessels, and one Capesize bulk carrier. Capital GP L.L.C. serves as the general partner of the company. The company was incorporated in 2007 and is headquartered in Piraeus, Greece.
Earnings Per Share
As for profitability, Capital Product Partners L.P. has a trailing twelve months EPS of $2.15.
PE Ratio
Capital Product Partners L.P. has a trailing twelve months price to earnings ratio of 8.24. Meaning, the purchaser of the share is investing $8.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.21%.
Volume
Today’s last reported volume for Capital Product Partners L.P. is 9358 which is 94.35% below its average volume of 165886.
Sales Growth
Capital Product Partners L.P.’s sales growth is 30.7% for the ongoing quarter and 31.8% for the next.
3. Towers Watson & Co (TW)
21.9% sales growth and 7.31% return on equity
Tradeweb Markets Inc., together with its subsidiaries, builds and operates electronic marketplaces worldwide. The company's marketplaces facilitate trading in a range of asset classes, including rates, credit, money markets, and equities. It offers pre-trade data and analytics, trade execution, and trade processing, as well as post-trade data, analytics, and reporting services. The company provides flexible order and trading systems to institutional investors. It also offers a range of electronic, voice, and hybrid platforms to dealers and financial institutions on electronic or hybrid markets with Dealerweb platform; and trading solutions for financial advisory firms and traders with Tradeweb Direct platform. The company serves in the institutional, wholesale, and retail client sectors. Its customers include asset managers, hedge funds, insurance companies, central banks, banks and dealers, proprietary trading firms, retail brokerage and financial advisory firms, and regional dealers. The company was founded in 1996 and is headquartered in New York, New York. Tradeweb Markets Inc. operates as a subsidiary of Refinitiv Parent Limited.
Earnings Per Share
As for profitability, Towers Watson & Co has a trailing twelve months EPS of $1.71.
PE Ratio
Towers Watson & Co has a trailing twelve months price to earnings ratio of 59.88. Meaning, the purchaser of the share is investing $59.88 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.31%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 25.9% and 23.1%, respectively.
Yearly Top and Bottom Value
Towers Watson & Co’s stock is valued at $102.40 at 01:22 EST, below its 52-week high of $108.04 and way higher than its 52-week low of $64.83.
4. Dominion Resources (D)
18.1% sales growth and 7.82% return on equity
Dominion Energy, Inc. produces and distributes energy in the United States. It operates through three operating segments: Dominion Energy Virginia, Dominion Energy South Carolina, and Contracted Energy. The Dominion Energy Virginia segment generates, transmits, and distributes regulated electricity to approximately 2.8 million residential, commercial, industrial, and governmental customers in Virginia and North Carolina. The Dominion Energy South Carolina segment generates, transmits, and distributes electricity to approximately 0.8 million customers in the central, southern, and southwestern portions of South Carolina; and distributes natural gas to approximately 0.4 million residential, commercial, and industrial customers in South Carolina. The Contracted Energy segment is involved in the nonregulated long-term contracted renewable electric generation and renewable natural gas facility. As of December 31, 2023, the company's portfolio of assets included approximately 29.5 gigawatt of electric generating capacity; 10,600 miles of electric transmission lines; 79,300 miles of electric distribution lines; and 94,800 miles of gas distribution mains and related service facilities. The company was formerly known as Dominion Resources, Inc. Dominion Energy, Inc. was incorporated in 1983 and is headquartered in Richmond, Virginia.
Earnings Per Share
As for profitability, Dominion Resources has a trailing twelve months EPS of $2.48.
PE Ratio
Dominion Resources has a trailing twelve months price to earnings ratio of 19.58. Meaning, the purchaser of the share is investing $19.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.82%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 29.3% and positive 15.1% for the next.
Moving Average
Dominion Resources’s worth is higher than its 50-day moving average of $46.35 and above its 200-day moving average of $47.58.
Volume
Today’s last reported volume for Dominion Resources is 3234540 which is 43.86% below its average volume of 5762420.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Feb 29, 2024, the estimated forward annual dividend rate is 2.67 and the estimated forward annual dividend yield is 5.56%.
5. Medpace Holdings (MEDP)
15.9% sales growth and 59.83% return on equity
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Earnings Per Share
As for profitability, Medpace Holdings has a trailing twelve months EPS of $8.89.
PE Ratio
Medpace Holdings has a trailing twelve months price to earnings ratio of 45.46. Meaning, the purchaser of the share is investing $45.46 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 59.83%.
Sales Growth
Medpace Holdings’s sales growth is 18.1% for the ongoing quarter and 15.9% for the next.
Volume
Today’s last reported volume for Medpace Holdings is 169537 which is 32.65% below its average volume of 251731.
6. STERIS (STE)
14.3% sales growth and 9.11% return on equity
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
Earnings Per Share
As for profitability, STERIS has a trailing twelve months EPS of $5.68.
PE Ratio
STERIS has a trailing twelve months price to earnings ratio of 37.58. Meaning, the purchaser of the share is investing $37.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.11%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
STERIS’s EBITDA is 4.88.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Feb 22, 2024, the estimated forward annual dividend rate is 2.08 and the estimated forward annual dividend yield is 0.89%.
Sales Growth
STERIS’s sales growth is 4.6% for the present quarter and 14.3% for the next.
7. Sprouts Farmers Market (SFM)
6.8% sales growth and 23.59% return on equity
Sprouts Farmers Market, Inc. offers fresh, natural, and organic food products in the United States. The company offers perishable product categories, including fresh produce, meat, seafood, deli, bakery, floral and dairy, and dairy alternatives; and non-perishable product categories, such as grocery, vitamins and supplements, bulk items, frozen foods, beer and wine, and natural health and body care. As of January 2, 2022, it operated 374 stores in 23 states. Sprouts Farmers Market, Inc. was founded in 2002 and is headquartered in Phoenix, Arizona.
Earnings Per Share
As for profitability, Sprouts Farmers Market has a trailing twelve months EPS of $2.5.
PE Ratio
Sprouts Farmers Market has a trailing twelve months price to earnings ratio of 25.57. Meaning, the purchaser of the share is investing $25.57 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.59%.
Moving Average
Sprouts Farmers Market’s worth is way higher than its 50-day moving average of $56.27 and way higher than its 200-day moving average of $44.94.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.7%, now sitting on 6.84B for the twelve trailing months.
Volume
Today’s last reported volume for Sprouts Farmers Market is 200925 which is 84.89% below its average volume of 1330410.
Sales Growth
Sprouts Farmers Market’s sales growth is 7.4% for the present quarter and 6.8% for the next.
8. Ingersoll (IR)
5.9% sales growth and 8.22% return on equity
Ingersoll Rand Inc. provides various mission-critical air, gas, liquid, and solid flow creation technologies services and solutions worldwide. It operates through two segments, Industrial Technologies and Services, and Precision and Science Technologies. The Industrial Technologies and Services segment designs, manufactures, markets, and services air and gas compression, vacuum, and blower products; fluid transfer equipment and loading systems; and power tools and lifting equipment, including associated aftermarket parts, consumables, air treatment equipment, controls, other accessories, and services under the under the Ingersoll Rand, Gardner Denver, Nash, CompAir, Elmo Rietschle brands, etc. The Precision and Science Technologies segment designs, manufactures, and markets diaphragm, piston, water-powered, peristaltic, gear, vane, progressive cavity, and syringe pumps; and gas boosters, hydrogen compression systems, automated liquid handling systems, odorant injection systems, controls, software, and other related components and accessories for liquid and gas dosing, transfer, dispensing, compression, sampling, pressure management, and flow control in specialized or critical applications under the Air Dimensions, Albin, ARO, Dosatron, Haskel, Ingersoll Rand, LMI, Maximus, Milton Roy, MP, Oberdorfer, Seepex, Thomas, Welch, Williams, YZ, and Zinnser Analytic brand names. This segment's products are used in medical, life sciences, industrial manufacturing, water and wastewater, chemical processing, energy, food and beverage, agriculture, and other markets. It sells through an integrated network of direct sales representatives and independent distributors. The company was formerly known as Gardner Denver Holdings, Inc. and changed its name to Ingersoll Rand Inc. in March 2020. Ingersoll Rand Inc. was founded in 1859 and is headquartered in Davidson, North Carolina.
Earnings Per Share
As for profitability, Ingersoll has a trailing twelve months EPS of $1.9.
PE Ratio
Ingersoll has a trailing twelve months price to earnings ratio of 49.9. Meaning, the purchaser of the share is investing $49.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.22%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Ingersoll’s EBITDA is 5.47.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.2%, now sitting on 6.88B for the twelve trailing months.
Yearly Top and Bottom Value
Ingersoll’s stock is valued at $94.81 at 01:22 EST, higher than its 52-week high of $92.44.
